Insilico Medicine Advances ISM6200 for Cancer Therapy
HONG KONG | April 10, 2026 Insilico Medicine has announced the nomination of ISM6200, a potential best-in-class selective NR3C1...
Generative AI
Advertisement
Insilico, Lilly Sign $2.75B AI Drug Discovery Deal
Hong Kong | March 30, 2026 Strategic AI Collaboration to Accelerate Drug Discovery Insilico Medicine has announced a major...
AI Drug Discovery Deal Expands CNS Pipeline Value
Hong Kong | March 30, 2026 AI Collaboration Accelerates CNS Drug Discovery Insilico Medicine and Tenacia Biotechnology have announced...
Manifold Bio Demonstrates AI Protein Design Breakthrough
Boston, Massachusetts, March 16, 2026 Manifold Bio, a platform therapeutics company focused on AI-driven drug discovery, announced breakthrough results...
Insilico Launches AI System for Biotech Partnering
March 3, 2026 Insilico Medicine, a clinical-stage biotechnology company known for its generative artificial intelligence platforms, has launched a...
Advertisements
AI Visibility Index Analyzes Fresh Dog Food Brands
New Report Maps How AI Prioritizes Pet Nutrition – February 18, 2026 | United States A new analytical report...
Advertisement
